pharmaphorum December 6, 2022
Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. Recognising an opportunity to develop better tools for clinical trial leaders to share and stream data, YonaLink’s co-founders built a software solution that addresses the interoperability gap in clinical trial operations. Iddo Peleg (CEO, and one of the four co-founders of YonaLink) and Gav Martell (co-founder and vice president of business development) discussed how a recent $6 million funding round led by Debiopharm Innovation Fund will support their mission to transform clinical trials and bring lifesaving therapies to market faster.
While many pieces of the drug development process have digitised to keep pace with the speed of technological advancements,...
Today's Sponsors
Today's Sponsor